Cargando…
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
BACKGROUND: Hospitalized patients with COVID‐19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well‐known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID‐19 is lacking. OBJECTIVES:...
Ejemplares similares
-
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
por: Li, Ang, et al.
Publicado: (2020) -
Crowdsourcing a crisis response for COVID-19 in oncology
por: Desai, Aakash, et al.
Publicado: (2020) -
LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
por: Grivas, P., et al.
Publicado: (2020) -
COVID-19 and Cancer: Current Challenges and Perspectives
por: Bakouny, Ziad, et al.
Publicado: (2020) -
Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
por: Rubinstein, Samuel, et al.
Publicado: (2020)